193 related articles for article (PubMed ID: 32775301)
1. OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma.
An Y; Wang Q; Zhang L; Sun F; Zhang G; Dong H; Li Y; Peng Y; Li H; Zhu W; Ji S; Wang Y; Guo X
Front Oncol; 2020; 10():1097. PubMed ID: 32775301
[TBL] [Abstract][Full Text] [Related]
2. OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma.
An Y; Wang Q; Zhang G; Sun F; Zhang L; Li H; Li Y; Peng Y; Zhu W; Ji S; Guo X
Front Pharmacol; 2020; 11():875. PubMed ID: 32587519
[TBL] [Abstract][Full Text] [Related]
3. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
5. A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma.
Xiao Y; Cui G; Ren X; Hao J; Zhang Y; Yang X; Wang Z; Zhu X; Wang H; Hao C; Duan H
Front Oncol; 2020; 10():605737. PubMed ID: 33381460
[TBL] [Abstract][Full Text] [Related]
6. OSeac: An Online Survival Analysis Tool for Esophageal Adenocarcinoma.
Wang Q; Yan Z; Ge L; Li N; Yang M; Sun X; Xie L; Zhang G; Zhu W; Wang Y; Li Y; Li X; Guo X
Front Oncol; 2020; 10():315. PubMed ID: 32211334
[TBL] [Abstract][Full Text] [Related]
7. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Patil V; Mahalingam K
Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns and the prognostic value of the EMILIN/Multimerin family members in low-grade glioma.
Zhao Y; Zhang X; Yao J; Jin Z; Liu C
PeerJ; 2020; 8():e8696. PubMed ID: 32175193
[TBL] [Abstract][Full Text] [Related]
9. OSgbm: An Online Consensus Survival Analysis Web Server for Glioblastoma.
Dong H; Wang Q; Li N; Lv J; Ge L; Yang M; Zhang G; An Y; Wang F; Xie L; Li Y; Zhu W; Zhang H; Zhang M; Guo X
Front Genet; 2019; 10():1378. PubMed ID: 32153627
[TBL] [Abstract][Full Text] [Related]
10. Fam20C Overexpression Predicts Poor Outcomes and is a Diagnostic Biomarker in Lower-Grade Glioma.
Feng J; Zhou J; Zhao L; Wang X; Ma D; Xu B; Xie F; Qi X; Chen G; Zhao H; Wu J
Front Genet; 2021; 12():757014. PubMed ID: 34970298
[TBL] [Abstract][Full Text] [Related]
11. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
[TBL] [Abstract][Full Text] [Related]
12. OSuvm: An interactive online consensus survival tool for uveal melanoma prognosis analysis.
Wang F; Wang Q; Li N; Ge L; Yang M; An Y; Zhang G; Dong H; Ji S; Zhu W; Guo X
Mol Carcinog; 2020 Jan; 59(1):56-61. PubMed ID: 31646691
[TBL] [Abstract][Full Text] [Related]
13. Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma.
Dong Q; Li Q; Wang M; Hu J; Dai J; Niu L; Yuan G; Pan Y
Oncol Lett; 2019 Oct; 18(4):3698-3704. PubMed ID: 31516582
[TBL] [Abstract][Full Text] [Related]
14. OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts.
Yan Z; Wang Q; Sun X; Ban B; Lu Z; Dang Y; Xie L; Zhang L; Li Y; Zhu W; Guo X
Front Oncol; 2019; 9():1349. PubMed ID: 31921624
[TBL] [Abstract][Full Text] [Related]
15. Elevated RECQL1 expression predicts poor prognosis and associates with tumor immune infiltration in low-grade glioma.
Wang G; Cen Y; Wang C; Xiang W; Li S; Ming Y; Chen L; Zhou J
Transl Cancer Res; 2022 Jun; 11(6):1552-1564. PubMed ID: 35836526
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
[TBL] [Abstract][Full Text] [Related]
17. OSlms: A Web Server to Evaluate the Prognostic Value of Genes in Leiomyosarcoma.
Wang Q; Xie L; Dang Y; Sun X; Xie T; Guo J; Han Y; Yan Z; Zhu W; Wang Y; Li W; Guo X
Front Oncol; 2019; 9():190. PubMed ID: 30984618
[TBL] [Abstract][Full Text] [Related]
18. OSpaad: An online tool to perform survival analysis by integrating gene expression profiling and long-term follow-up data of 1319 pancreatic carcinoma patients.
Zhang G; Wang Q; Yang M; Yao X; Qi X; An Y; Dong H; Zhang L; Zhu W; Li Y; Guo X
Mol Carcinog; 2020 Mar; 59(3):304-310. PubMed ID: 31912599
[TBL] [Abstract][Full Text] [Related]
19. Systemic screening identifies GABRD, a subunit gene of GABAA receptor as a prognostic marker in adult IDH wild-type diffuse low-grade glioma.
Zhang H; Zhang L; Tang Y; Wang C; Chen Y; Shu J; Zhang K
Biomed Pharmacother; 2019 Oct; 118():109215. PubMed ID: 31545245
[TBL] [Abstract][Full Text] [Related]
20. Expression of FAS-L Differs from Primary to Relapsed Low-grade Gliomas and Predicts Progression-free Survival.
Werner JM; Kuhl S; Stavrinou P; Röhn G; Krischek B; Blau T; Goldbrunner R; Timmer M
Anticancer Res; 2017 Dec; 37(12):6639-6648. PubMed ID: 29187439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
